HC Wainwright Lowers Earnings Estimates for Vivani Medical

Vivani Medical, Inc. (NASDAQ:VANI) – Equities researchers at HC Wainwright reduced their FY2024 earnings per share estimates for Vivani Medical in a note issued to investors on Thursday, March 13th. HC Wainwright analyst Y. Chen now expects that the company will earn ($0.43) per share for the year, down from their previous forecast of ($0.41). HC Wainwright has a “Buy” rating and a $4.00 price objective on the stock. The consensus estimate for Vivani Medical’s current full-year earnings is ($0.41) per share. HC Wainwright also issued estimates for Vivani Medical’s Q1 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.09) EPS, Q4 2025 earnings at ($0.09) EPS and FY2025 earnings at ($0.39) EPS.

Vivani Medical Trading Down 0.9 %

Vivani Medical stock opened at $1.09 on Monday. Vivani Medical has a 12 month low of $1.03 and a 12 month high of $2.22. The stock’s 50 day moving average is $1.15 and its 200-day moving average is $1.22. The company has a market capitalization of $64.57 million, a price-to-earnings ratio of -2.42 and a beta of 3.20.

Institutional Investors Weigh In On Vivani Medical

A number of large investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC grew its position in Vivani Medical by 4.6% during the third quarter. Geode Capital Management LLC now owns 342,891 shares of the company’s stock worth $401,000 after buying an additional 15,008 shares in the last quarter. Northern Trust Corp grew its position in Vivani Medical by 19.1% during the fourth quarter. Northern Trust Corp now owns 71,915 shares of the company’s stock worth $83,000 after buying an additional 11,540 shares in the last quarter. Jane Street Group LLC acquired a new stake in Vivani Medical during the fourth quarter worth approximately $66,000. Finally, Wealthedge Investment Advisors LLC acquired a new stake in Vivani Medical during the fourth quarter worth approximately $43,000. Institutional investors and hedge funds own 6.78% of the company’s stock.

Vivani Medical Company Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.